The excellence collective

News and updates relevant to members of the Epilepsy Action Excellence Collective

Covid no more likely than flu to lead to epilepsy
Covid no more likely than flu to lead to epilepsy
Grace Wood | The study compared patients who were hopsitalised with Covid-19 to patients who were admitted with flu
Neurological conditions leading cause of illness – study
Neurological conditions leading cause of illness – study
Grace Wood | According the to the study, in 2021 3.4 billion people had a neurological condition
Swansea University study shows impact of Covid and epilepsy
Swansea University study shows impact of Covid and epilepsy
Grace Wood | The research into Covid and epilepsy was supported by Epilepsy Action
UCL team develop mental health treatment for children with epilepsy
UCL team develop mental health treatment for children with epilepsy
Grace Wood | The mental health treatment for children with epilepsy was published in The Lancet
Spring Budget 2024: funding for epilepsy research announced
Spring Budget 2024: funding for epilepsy research announced
Grace Wood | Hunt announced a £45 million investment into research for cancer, dementia and epilepsy
Epilepsy medicine shortages continue
Epilepsy medicine shortages continue
Epilepsy Action’s helpline has seen five times more enquiries on medication stock
Neurology crisis costing UK £96bn – Economist report
Neurology crisis costing UK £96bn – Economist report
The report was launched at the House of Commons on February 26, 2024
People with epilepsy more likely to get Parkinson’s disease
People with epilepsy more likely to get Parkinson’s disease
Grace Wood | According to the research, 21 in 10,000 people with epilepsy will develop Parkinson’s disease
‘Huge and unjust disparities’ across NHS neurology services
‘Huge and unjust disparities’ across NHS neurology services
Grace Wood | There is one neurologist to every 755 people with epilepsy in the North East, but one to every 191 in London
Page 1 of 3